Related Experiment Video
Updated: Aug 26, 2026

Murine Surgical Model of Topical Elastase Induced Descending Thoracic Aortic Aneurysm
Published on: August 24, 2019
Matrix metalloproteinase activity in thoracic aortic aneurysms associated with bicuspid and tricuspid aortic valves
Jon Boyum1, Erika K Fellinger, Joseph D Schmoker
1Department of Surgery, Division of Cardiothoracic Surgery, Fletcher Allen Health Care, Fletcher 454, 111 Colchester Avenue, Burlington, VT 05401, USA.
Objective:
Matrix metalloproteinases are endopeptidases that function in cell matrix turnover. Abnormal matrix metalloproteinase activity has been implicated in the formation of atherosclerotic abdominal aortic aneurysms. Recent studies suggest that abnormal matrix metalloproteinase activity may also be associated with the formation of atherosclerotic and nonatherosclerotic thoracic aortic aneurysms. Bicuspid aortic valves are associated with an intrinsic aortic pathology that predisposes to formation of proximal thoracic aneurysms while tricuspid aortic valves are not. The objective of this study was to compare the activities of matrix metalloproteinases and levels of their inhibitors in thoracic aneurysms of patients with bicuspid and tricuspid aortic valves.
Methods:
Endogenous and total activity of matrix metalloproteinase-2 and matrix metalloproteinase-9 were measured in proximal nonatherosclerotic thoracic aortic aneurysms of 16 patients with bicuspid aortic valves and 12 patients with tricuspid aortic valves. Levels of tissue inhibitor metalloproteinase-1 and -2 were also measured. Results were standardized to total protein (mg).
Results:
Total matrix metalloproteinase-2 activity was greater in aneurysms associated with bicuspid valves when compared with those from tricuspid valves (43 +/- 11 ng/mg vs 14 +/- 2 ng/mg, P =.02). Total matrix metalloproteinase-9 activity was also greater in aneurysms associated with bicuspid aortic valves (4.0 +/- 0.9 vs 1.5 +/- 0.3, P =.02). There was no meaningful difference between groups in levels of tissue inhibitor-1 and -2.
Conclusion:
The increased activity of matrix metalloproteinases in the walls of aneurysms associated with bicuspid aortic valves may partly explain the predilection to aneurysm formation in these patients.
Insights
Matrix metalloproteinase activity is higher in thoracic aortic aneurysms associated with bicuspid aortic valves compared to tricuspid aortic valves. This may explain the increased risk of aneurysm formation in patients with bicuspid aortic valves.
Area of Science:
- Cardiovascular Research
- Aortic Pathology
- Biochemistry
Background:
- Matrix metalloproteinases (MMPs) are crucial for cell matrix turnover.
- Abnormal MMP activity is linked to abdominal aortic aneurysms and potentially thoracic aortic aneurysms.
- Bicuspid aortic valves predispose to proximal thoracic aneurysms, unlike tricuspid valves.
Purpose of the Study:
- To compare MMP activities and their inhibitors in thoracic aneurysms.
- To investigate differences between bicuspid and tricuspid aortic valve patients.
Main Methods:
- Measured endogenous and total MMP-2 and MMP-9 activity in thoracic aneurysms.
- Quantified tissue inhibitor of metalloproteinase-1 and -2 levels.
- Included 16 patients with bicuspid and 12 with tricuspid aortic valves.
Main Results:
- Total MMP-2 activity was significantly higher in bicuspid aortic valve aneurysms (43 ng/mg) versus tricuspid (14 ng/mg).
- Total MMP-9 activity was also significantly elevated in bicuspid aortic valve aneurysms (4.0 ng/mg) versus tricuspid (1.5 ng/mg).
- No significant difference in tissue inhibitor levels between the groups.
Conclusions:
- Elevated MMP activity in bicuspid aortic valve-associated aneurysms may contribute to aneurysm development.
- These findings highlight a potential mechanism for aneurysm formation in bicuspid aortic valve disease.
Related Concept Videos
Role of Matrix Metalloproteases in Degradation of ECM
A...
Aneurysm II: Clinical Manifestations and Diagnostic Studies
Aortic Regurgitation III: Medical Management
Aortic Regurgitation II: Clinical Features and Diagnostic Tests
